关于系统性硬化症研究未来的国际视角
David J Abraham1, Carol M Black2, Christopher P Denton2
1Department of Inflammation and Rare Diseases, UCL Centre for Rheumatology, UCL Division of Medicine, Royal Free Hospital Campus, London, UK. david.abraham@ucl.ac.uk.
Nature reviews. Rheumatology
|February 14, 2025
概括
系统性硬化症 (SSc) 研究面临的挑战是由于其复杂性和缺乏治疗方法. 先进的技术为了解SSc病原体和开发个性化治疗提供了新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 遗传学 遗传学 是一个
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,其病因不明,异质,有效治疗方法有限.
- 在SSc中微血管功能障碍,自身免疫和纤维化之间的联系仍然不太清楚.
- 缺乏验证的生物标志物和动物模型阻碍了诊断和治疗,导致高发病率和死亡率.
研究的目的:
- 探索了解系统性硬化症 (SSc) 病变的最新进展.
- 确定早期诊断和有效治疗SSc.的新途径.
- 强调对SSc突破的综合,协作研究的需要.
主要方法:
- 综述高通量技术的最新进展:单细胞RNA测序,下一代测序,空间生物学,转录组学,基因组学,蛋白质组学,代谢组学,微生物组分析和人工智能.
- 分析疾病分类,异质性和生物标志物开发方面的挑战.
- 考虑创新的临床试验设计和新兴疗法.
主要成果:
- 先进的奥米克和人工智能技术为识别早期SSc病原遗传事件提供了新的机会.
- 通过全球协作努力整合各种数据对于机械学理解至关重要.
- 新兴疗法,包括基于细胞和向纤维细胞的治疗方法,显示出有前途.
结论:
- 整合先进的研究技术为SSc诊断,治疗和患者护理提供了潜在的突破.
- 解决分类,异质性和生物标志物的挑战对于进步至关重要.
- 全球合作和跨学科研究对于改善SSC成果至关重要.
更多相关视频
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
8.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
369
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K